KYMERA THERAPEUTICS I
43.04
08-10月-24 15:59:58
15 分の遅延
株式
+0.83
+1.97%
本日の幅
42.41 - 43.90
ISIN
N/A
ソース
NASDAQ
-
29 7 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
06 7 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
30 6 2021 21:45:35 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Proposed Public Offering of Common Stock
28 6 2021 16:36:38 提供 Nasdaq GlobeNewswire
-
28 6 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Appoints Elaine Caughey, MBA, as Chief Business Officer
21 6 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
02 6 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
26 5 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
10 5 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update
06 5 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Appoints Juliet Williams, PhD, as Senior Vice President, Head of Biology
05 5 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Present at Upcoming May Investor Conferences
04 5 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
03 5 2021 16:00:40 提供 Nasdaq GlobeNewswire
-
Kymera Therapeutics Honored by Boston Business Journal as a 2021 Best Places to Work Company
19 4 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
10 4 2021 08:30:00 提供 Nasdaq GlobeNewswire